Login to Your Account

Clinic Roundup

Friday, March 25, 2011
Stemedica Cell Technologies Inc., of San Diego, said its ischemic adult allogeneic mesenchymal stem cells were used successfully to treat the first patient in an ischemic stroke study. A total of 35 patients will be enrolled in the study, which is designed to determine tolerance and therapeutic outcomes for the intravenously delivered stem cells.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription